Richmond Pharmacology is delighted to confirm an upcoming event alongside the Department of International Trade in the US.Early Phase Drug Development in the UK is to take place Friday 28th of September in Boston, MA.

Click here to RSVP

The event which is to host speakers from both Richmond Pharmacology and UK regulators continues a long line of events staged between Richmond Pharmacology and the DIT around the world. Full details found below including how to express interest in attending the event.

Friday, 28 September 2018Time TBC

Café ArtScience650 East Kendall St,Cambridge, MA 02142

Click here to RSVP

Full schedule to follow, please email j.wilmott@richmondphramacology.com confirm interest in attending.

Supported By:

Latest news

Patient safety is not an afterthought. Explore our new infographic!

September 17, 2025
Patient safety is not an afterthought; it is the foundation of every clinical trial.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event